UK Markets closed

Investors want $2.5 billion in class action over Bayer's Monsanto deal-report

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

FRANKFURT (Reuters) - Investors are set to demand around 2.2 billion euros ($2.5 billion) from Bayer as part of a possible class action lawsuit in Germany over the takeover of U.S. seed manufacturer Monsanto, WirtschaftsWoche reported on Monday.

Citing a statement from specialist law firm Tilp Rechtsanwaltsgesellschaft, the magazine said that as of Dec. 31, the sum covered lawsuits from about 320 investors, both institutional and retail.

This represents a significant jump from the 250-plus investors demanding damages of more than 1 billion euros that Tilp disclosed last month.

Tilp has said it believes Bayer deceived shareholders about the risks of consumer lawsuits pending in the United States linked to the weed killer Roundup, which was brought into the company with the $63 billion acquisition of Monsanto in 2016.

Bayer, in an emailed statement, said any complaints were unfounded, adding the company had complied with the law and disclosure requirements.

"In addition we are convinced that we have carried out adequate due diligence regarding the acquisition of Monsanto," Bayer said, adding it would defend itself accordingly.

Tilp was not immediately available for comment.

In the United States, Bayer is defending itself against thousands of lawsuits by Roundup users because of the alleged carcinogenic effect of the product. Bayer has always rejected this.

($1 = 0.8857 euros)

(Reporting by Christoph Steitz; Editing by Mark Potter)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting